Back to Search Start Over

Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71].

Authors :
Escudier B
Sharma P
McDermott DF
George S
Hammers HJ
Srinivas S
Tykodi SS
Sosman JA
Procopio G
Plimack ER
Castellano D
Gurney H
Donskov F
Peltola K
Wagstaff J
Gauler TC
Ueda T
Zhao H
Waxman IM
Motzer RJ
Source :
European urology [Eur Urol] 2018 Apr; Vol. 73 (4), pp. e116-e118. Date of Electronic Publication: 2018 Jan 03.
Publication Year :
2018

Details

Language :
English
ISSN :
1873-7560
Volume :
73
Issue :
4
Database :
MEDLINE
Journal :
European urology
Publication Type :
Academic Journal
Accession number :
29306512
Full Text :
https://doi.org/10.1016/j.eururo.2017.12.016